Medpace Holdings (MEDP) Tops Q2 EPS by 27c; offers guidance

Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $4.25, $0.27 better than the analyst estimate of $3.98. Revenue for the quarter came in at $707.3 million versus the consensus estimate of $690.68 million.

GUIDANCE:

Medpace Holdings sees FY2026 EPS of $17.25-$17.95, versus the consensus of $17.12. Medpace Holdings sees FY2026 revenue of $2.805-2.885 million, versus the consensus of $2.772 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• First Reliance Bancshares, Inc. (FSRL) Reports In-Line Q2 EPS
• Peoples Financial Corp/ms (PFBK) Tops Q2 EPS by 19c